← Eichor
Condition: Keratoplasty Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Keratoplasty

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

SUCCESS Score Validation in Fuchs Dystrophy
Phase N/A · 1 location(s) · Instituto Ramón y Cajal de Investigación Sanitaria · NCT07265388The Homburg Keratoconus Center (HKC)
Phase N/A · 1 location(s) · Universität des Saarlandes · NCT03923101Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty
Phase 1 · 1 location(s) · Singapore Eye Research Institute · NCT04319848Postoperative Outcomes of a Toric AddOn Intraocular Lens After Keratoplasty and Cataract Surgery
Phase N/A · 1 location(s) · Medical University of Vienna · NCT07452042Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy
Phase 4 · 1 location(s) · Marian Macsai, MD · NCT03249337Microsurgical Robot-assisted Corneal Transplant
NA · 1 location(s) · CHU de Reims · NCT06844123DSAEK/DMEK and Cystoid Macular Edema - the Role for Topical NSAIDs (Nepafenac) (DMEC)
Phase 4 · 1 location(s) · Oslo University Hospital · NCT05072262The German Keratoplasty Registry of the German Ophthalmological Society (DOG)
Phase N/A · 1 location(s) · Universität des Saarlandes · NCT03381794The OPTIMISE Study
Phase 4 · 8 location(s) · Maastricht University Medical Center · NCT05716945Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the Eye
Phase N/A · 1 location(s) · Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07634913Phase III Presbyopia Correction Using the VIS Opti-K™ System
Phase 3 · 4 location(s) · VIS, Inc. · NCT06487897DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy
Phase 2 · 2 location(s) · Design Therapeutics, Inc. · NCT07024693Prognosis of Posterior Lamellar Keratoplasty
Phase N/A · 1 location(s) · Centre Hospitalier Régional Metz-Thionville · NCT06859411Effectiveness of PKP vs DSAEK in Terms of 2-year Postoperative Visual Acuity in Advanced BPK
NA · 11 location(s) · Centre Hospitalier Régional Metz-Thionville · NCT06818747DMEK Endothelial Keratoplasty in Patients With a History of Anterior or Posterior Segment Surgery
Phase N/A · 1 location(s) · Fondation Ophtalmologique Adolphe de Rothschild · NCT06013462Study of the Anatomical and Functional Recovery and Quality of Life of Patients Undergoing Corneal Transplantation
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06830538Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy
Phase 2 · 1 location(s) · Massachusetts Eye and Ear Infirmary · NCT04440280The Belgian Endothelial Surgical Transplant of the Cornea
NA · 11 location(s) · University Hospital, Antwerp · NCT05436665Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]
NA · 7 location(s) · Claus Cursiefen · NCT05870566PVEK Corneal Implant For Treatment of Corneal Edema
Phase 1 · 3 location(s) · Precise Bio · NCT07325097The Viability Control of Human Endothelial Cells Before Keratoplasty (V-CHECK) Study
Phase N/A · 12 location(s) · Azienda Socio Sanitaria Territoriale degli Spedali Civili di · NCT05847387Influence of Supine Positioning on the Outcomes After Descemet Membrane Endothelial Keratoplasty (DMEK)
NA · 1 location(s) · University Hospital Heidelberg · NCT07373821ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty
Phase 2 · 12 location(s) · Massachusetts Eye and Ear Infirmary · NCT06753916First in Human Study to Assess Safety and Efficacy of an Implantable Nitinol Device in the Treatment of Keratoconus
NA · 2 location(s) · Recornea Srl · NCT06451718Dresden Corneal Disease and Treatment Study
Phase N/A · 1 location(s) · Technische Universität Dresden · NCT04251143AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction
Phase 3 · 12 location(s) · Aurion Biotech · NCT07368959Topical Infliximab in Eyes With Penetrating Keratoplasty
Phase 1/Phase 2 · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05180994
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.